Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch
Home Healthcare Inflation Is Stubbornly High -- WSJ
China leads the body, NVIDIA aims to be the brain, and Tesla "integrates" — Morgan Stanley elaborates on the top 100 humanoid robot companies!
Morgan Stanley systematically sorted out 100 core listed companies in the Global humanoid robot Industry Chain from the three core links of "brain", "body" and "integrator" for the first time, and pointed out that China holds a 63% share in the humanoid robot supply chain, dominating the market, especially with significant advantages in the "body" segment, while technology giants like Tesla and NVIDIA have become key forces in each segment.
U.S. stock market movement | Robot Concept stocks rise, Palladyne AI (PDYN.US) increases by over 28%.
U.S. stocks in the Robot Concept sector surged strongly, and as of this report, Palladyne AI has increased by over 28%.
Vicarious Surgical Secures Advisory Role With Former CFO
BTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)
Vicarious Surgical: Kelly Will Assist Co to Ensure Successful Transition Prior to His Departure, Which Is Slated for Jan 2 >RBOT
Express News | Vicarious Surgical Inc - William Kelly to Depart as CFO on January 2, 2025
Vicarious Surgical Announces Departure Of Chief Financial Officer >RBOT
Express News | Vicarious Surgical Announces Departure of Chief Financial Officer
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Vicarious Surgical Is Maintained at Neutral by Piper Sandler
Vicarious Surgical Analyst Ratings
TD Cowen Maintains Vicarious Surgical(RBOT.US) With Buy Rating, Raises Target Price to $13
Promising Milestones and Financial Prudence Drive Buy Rating for Vicarious Surgical
BTIG Maintains Vicarious Surgical(RBOT.US) With Hold Rating
Vicarious Surgical (RBOT) Gets a Hold From BTIG
Express News | Vicarious Surgical Inc : Piper Sandler Cuts Target Price to $10.50 From $12
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript Summary
Vicarious Surgical | 10-Q: Q3 2024 Earnings Report